YK-11 – 5mg

$105.00

YK-11 5mg (methyl (2E)-2-[(3r,5aS,6R,8aS,9R,10A-S,11S,12aS)-6-fluoro-11-hydroxy-10a,12a-dimethyl-1,3,4,5,5a,6,7,8,8a,9,10,11,12,12a-dodecahydrospiro[cyclopenta[a]phenanthrene-2,2′-[1,3]dioxolane]-3-yl]acetate) is a unique steroidal selective androgen receptor modulator (SARM) and gene-modulating myostatin inhibitor. Engineered to bypass natural genetic limits on muscle growth, YK-11 binds to androgen receptors to induce significant expression of follistatin—a naturally occurring glycoprotein that directly neutralizes myostatin. By deactivating the body’s natural limits on muscle expansion, YK-11 5mg promotes dense muscle fiber hypertrophy, skeletal strength, and cellular recovery without converting into estrogen. Third-party HPLC lab-tested to guarantee active compound purity exceeding 98%.

Category:
Description

The Ultimate Guide to Myostatin Inhibition, Follistatin Activation, and Extreme Mass Hypertrophy

When your strength training and physical development reach a persistent plateau, natural genetic boundaries like myostatin—the body’s innate regulatory protein that restricts muscle growth—can halt further progress. That is where YK-11 5mg stands as one of the most advanced, specialized compounds in modern sports biochemistry.
Unlike baseline selective androgen receptor modulators that solely rely on androgen receptor binding to stimulate tissue repair, YK-11 5mg features a unique steroidal backbone that acts on gene expression directly. By stimulating muscle cells to produce elevated levels of follistatin, it turns off myostatin’s restrictive signals and opens the pathway for muscle mass accumulation. Understanding its cellular pathways, daily dosing schedules, and post-cycle needs is key to utilizing this compound effectively.

What Is YK-11 5mg?

YK-11 5mg was first studied by Japanese researcher Yuichiro Kanno in 2011. While often categorized as a SARM due to its high selectivity for skeletal muscle tissue, its molecular architecture features a steroidal core structure closely related to dihydrotestosterone (DHT) derivatives.
What makes YK-11 5mg unique in performance research is its double mechanism of action: it acts as a partial agonist at androgen receptors in muscle tissue, while simultaneously signaling muscle cells to synthesize and secrete elevated levels of follistatin. Because follistatin binds to and neutralizes myostatin, YK-11 5mg effectively removes the physiological brakes on muscle growth, enabling rapid skeletal muscle cell expansion.

Scientific Research & Clinical Foundations

Peer-reviewed endocrinology and cellular biology literature document the unique gene-modulating properties of YK-11. Landmark research published on PubMed (NIH) confirms that YK-11 induces muscle cells (myoblasts) to produce significantly higher levels of follistatin than conventional anabolic agents, driving substantial increases in key anabolic markers like key myogenic factors. Additional research indexed through NCBI / PubMed Central demonstrates that YK-11 promotes osteoblast proliferation, increasing bone mineral density alongside muscle fiber hypertrophy without triggering non-selective androgenic strain on secondary organs.

How YK-11 5mg Works in the Human Body

To understand why YK-11 5mg is favored by advanced lifters, physique competitors, and researchers seeking to break through muscle mass limits, it helps to analyze its core biological mechanisms:

1. Follistatin Induction & Myostatin Blockade

Myostatin naturally acts as a chemical limit to prevent muscles from growing excessively large. The primary power of YK-11 5mg lies in its ability to upregulate follistatin production, which binds to myostatin directly, preventing it from halting muscle protein synthesis and allowing fibers to expand beyond standard genetic limits.

2. High-Selectivity Androgen Receptor Agonism

In addition to its follistatin signaling, YK-11 5mg binds to androgen receptors in skeletal muscle and bone tissue. This triggers intracellular pathways that increase nitrogen retention, enhance amino acid transport, and accelerate muscle cell repair following heavy lifting.

3. Accelerated Bone Mineral Remodeling

By stimulating osteoblast gene expression and increasing key bone-building markers, YK-11 5mg strengthens bone matrix density. This structural reinforcement helps support the rapid increases in muscle mass and heavy training loads enabled by myostatin inhibition.

4. Non-Aromatizing Dry Growth

Because YK-11 5mg lacks the molecular features required to interact with the aromatase enzyme, it does not convert into estrogen. Mass built during your cycle is completely dry, dense muscle, free from fluid retention or gynecomastia.

YK-11 5mg Dosing, Protocols, and Split Timing Guidelines

Because YK-11 5mg possesses a shorter biological half-life than once-daily SARMs like Testolone or Ostarine, establishing a split daily administration routine helps maintain steady plasma concentrations.

Biological Half-Life & Daily Schedule

  • Elimination Half-Life: Approximately 6 to 10 hours.

Protocol Application Examples:

1. Advanced Mass & Myostatin Inhibition Protocol

  • Daily Dose: 5mg to 10mg daily (e.g., one 5mg capsule taken in the morning with food, or split into 5mg in the morning and 5mg in the late afternoon for advanced protocols).
  • Cycle Duration: Standard advanced cycles run for 6 to 8 weeks.
  • Primary Objective: Deactivate myostatin limits, drive dense muscle hypertrophy, and increase overall muscle fiber density.

2. Post-Cycle Therapy (PCT) Requirement

  • Due to its high binding activity at androgen receptors, YK-11 5mg causes noticeable temporary suppression of baseline endogenous testosterone levels. A comprehensive PCT protocol using Arimistane (50mg) or GnRH (Triptorelin) 2mg should begin immediately following your cycle.

Stacking YK-11 5mg for Peak Anabolic Synergy

Combining gene-modulating compounds like YK-11 5mg with complementary research protocols creates multi-angled conditioning stacks:

YK-11 5mg vs. Other High-Potency Performance Compounds

Biological Parameter YK-11 5mg Standalone RAD-140 Standalone S-23
Primary Unique Pathway Follistatin Upregulation (Myostatin Blockade) High Neuromuscular Drive Extreme $K_i$ Binding Affinity
Estrogen Conversion Zero (Non-Aromatizing) Zero Zero
Physical Appearance Dense, Full Mass Growth Dry, Grainy Strength Extreme 3D Hardness
Half-Life / Dosing ~6 to 10 Hours (Split Dosing Recommended) ~24 to 60 Hours (Once Daily) ~12 Hours (Split Dosing)
Bone Density Impact High (Osteoblast Activation) High Moderate

Summary & Next Steps

When your physical conditioning goals require bypassing natural myostatin limits, upregulating follistatin expression, driving muscle fiber growth, and building dense skeletal tissue, YK-11 5mg stands out as a unique, powerful compound. By removing the biological barriers to muscle expansion, it helps you reach new levels of physical development.
Ready to shatter your genetic limits and deactivate myostatin? Order your lab-verified YK-11 – 5mg today!
Additional information
Packaging

Vial

Strength

5mg

Shipping & Delivery